EPA Allowed Bayer to Select Dicamba Weedkiller Regulations

The U.S. Environmental Protection Agency (EPA) permitted the pesticide giant Bayer to select regulatory options for its controversial and destructive weedkiller, dicamba, according to newly released internal agency documents. This process, typically conducted out of public view, offered an unusually clear look into the development of pesticide regulations. The documents detail how the EPA presented Bayer with a menu of mitigation options for dicamba, and subsequently incorporated Bayer's chosen regulations into a proposed federal rule. This proposed rule was later published on regulations.gov under the identifier EPA-HQ-OPP-2024-0154-1239. The weedkiller dicamba has been a subject of significant controversy due to its tendency to drift and damage non-target crops, leading to widespread agricultural disputes and legal challenges. Bayer, a multinational pharmaceutical and life sciences company, acquired Monsanto in 2018, inheriting its significant agricultural division, including the dicamba herbicide business. The company has been a major player in the agricultural chemical market for decades, developing and marketing a wide range of pesticides, seeds, and other crop protection products. The EPA's role is to regulate pesticides to protect human health and the environment. However, this instance raises questions about the extent of industry influence in the regulatory process. The documents suggest a collaborative approach between the regulatory body and the regulated entity, where the company effectively helped shape the rules governing its own product. This practice could be interpreted as a conflict of interest, potentially undermining the EPA's mandate to ensure public and environmental safety independently. Environmental advocacy groups have long raised concerns about the potential for regulatory capture, where industries exert undue influence over the agencies that are supposed to regulate them. The release of these documents by the EPA, following a request, has provided concrete evidence for such concerns regarding dicamba. The specific details of the mitigation options offered to Bayer and the exact choices made by the company are crucial for understanding the scope of this regulatory interaction. The implications of this arrangement extend to the broader debate on pesticide regulation, agricultural practices, and the balance of power between government agencies and large corporations in environmental policy-making. Further analysis of the proposed rule and Bayer's response is necessary to fully assess the impact on farmers, the environment, and the integrity of the regulatory framework.